SPSC close: $172 on 2023-08-21 to $81 on 2026-08-21.
Split-adj closes · 240 of 4,106 · price returnⓘ
At a glance
Short interest8.0% of sh out
Days to cover4.9d
13F net flow (QoQ)+3.41%
Top-10 13F concentration49.1%
Next report (est.)2026-10-29
SI 2026-07-31 · 13F 2026-Q1ⓘ
Key fundamentalsFY 2025
P/E (FY)33.0×
Sales (TTM)$772.5M
Earnings (TTM)$78.0M
ROE10.2%
Net margin12.4%
ROIC12.4%
EPS growth 3Y18.2%
Sales growth 3Y18.6%
FY ratios · TTM sales/earnings (USD)ⓘ
Trailing returns
YTD−9.0%
1Y−28.4%
3Y−53.0%
5Y−36.9%
10Y+145.2%
Since incept. (ann.)+16.4%
Total return · from 2010-04-22ⓘ
Risk
Ann. volatility (1Y)46.0%
Ann. volatility (3Y)41.7%
Sharpe (1Y)−0.46
Sharpe (3Y)−0.39
Max drawdown (1Y)−56.9%
Max drawdown (3Y)−76.8%
Beta (3Y vs SPY)0.86
Daily returns, ann.ⓘ
Top institutional holders13F 2026-Q1
Manager
Shares
Value
% sh out
QoQ
BlackRock, Inc.
5.8M
$324M
15.88%
+1.9%
VANGUARD PORTFOLIO MANAGEMENT LLC
3.0M
$165M
8.06%
new
NEUBERGER BERMAN GROUP LLC
1.8M
$100M
4.88%
+26.5%
VANGUARD CAPITAL MANAGEMENT LLC
1.7M
$95M
4.63%
new
STATE STREET CORP
1.5M
$83M
4.09%
+2.1%
Van Berkom & Associates Inc.
1.4M
$76M
3.69%
+119.9%
Anson Funds Management LP
1.1M
$64M
3.13%
new
GOLDMAN SACHS GROUP INC
1.1M
$60M
2.91%
+61.6%
Δ vs 2025-Q4 · Institutional 13F holdings sum to 107.4% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 2,762,684 shares (settlement 2026-05-15) accounts for the excess.ⓘ
Latest reported quarterslast report 2026-07-30
Period end
Reported
EPS
EPS YoY
Revenue
Rev YoY
2026-06-30
2026-07-30
$0.19
−63.5%
$197.8M
+5.6%
2026-03-31
2026-04-30
$0.53
−8.6%
$192.1M
+5.8%
2025-12-31
2026-02-12
$0.69
+50.0%
$192.7M
+12.7%
2025-09-30
2025-10-30
$0.67
+8.1%
$189.9M
+16.0%
As-reported XBRL · next 2026-10-29 est.ⓘ
Basis & disclosures
EOD closes · nothing imputed or averaged · absent “—”
As-of differs by block · 13F = US long, 45+d lag, LOWER bound
Not investment advice · no recommendation, price target or solicitation
EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
